 | Up a level |
Journal Article
Saalfeld, Felix C., Wenzel, Carina 
ORCID: 0000-0001-5869-6934, Christopoulos, Petros ORCID: 0000-0002-7966-8980, Merkelbach-Bruse, Sabine, Reissig, Timm M., Lassmann, Silke, Thiel, Sebastian, Stratmann, Jan A., Marienfeld, Ralf, Berger, Johannes, Desuki, Alexander, Velthaus, Janna-Lisa, Kauffmann-Guerrero, Diego, Stenzinger, Albrecht, Michels, Sebastian, Herold, Thomas, Kramer, Michael, Herold, Sylvia, Tufman, Amanda, Loges, Sonja ORCID: 0000-0002-7650-8527, Alt, Jurgen, Joosten, Maria, Schmidtke-Schrezenmeier, Gerlinde, Sebastian, Martin, Stephan-Falkenau, Susann, Waller, Cornelius F., Wiesweg, Marcel, Wolf, Juergen, Thomas, Michael, Aust, Daniela E. and Wermke, Martin
(2021).
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations.
J. Thorac. Oncol., 16 (11).
S. 1952 - 1959.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1556-1380
Stratmann, Jan A., Michels, Sebastian, Hornetz, Sofia, Christoph, Daniel C., Sackmann, Sandra, Spengler, Werner, Bischoff, Helge, Schaefer, Monica, Alt, Juergen, Mueller, Annette, Laack, Eckart, Kimmich, Martin, Griesinger, Frank and Sebastian, Martin (2018). Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer. J. Cancer Res. Clin. Oncol., 144 (12). S. 2457 - 2464. NEW YORK: SPRINGER. ISSN 1432-1335